Literature DB >> 28052101

Defining Transcriptional Regulatory Mechanisms for Primary let-7 miRNAs.

Xavier Gaeta1,2, Luat Le3, Ying Lin2, Yuan Xie3, William E Lowry1,2,3,4.   

Abstract

The let-7 family of miRNAs have been shown to control developmental timing in organisms from C. elegans to humans; their function in several essential cell processes throughout development is also well conserved. Numerous studies have defined several steps of post-transcriptional regulation of let-7 production; from pri-miRNA through pre-miRNA, to the mature miRNA that targets endogenous mRNAs for degradation or translational inhibition. Less-well defined are modes of transcriptional regulation of the pri-miRNAs for let-7. let-7 pri-miRNAs are expressed in polycistronic fashion, in long transcripts newly annotated based on chromatin-associated RNA-sequencing. Upon differentiation, we found that some let-7 pri-miRNAs are regulated at the transcriptional level, while others appear to be constitutively transcribed. Using the Epigenetic Roadmap database, we further annotated regulatory elements of each polycistron identified putative promoters and enhancers. Probing these regulatory elements for transcription factor binding sites identified factors that regulate transcription of let-7 in both promoter and enhancer regions, and identified novel regulatory mechanisms for this important class of miRNAs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28052101      PMCID: PMC5215532          DOI: 10.1371/journal.pone.0169237

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The let-7 family of miRNAs were first identified in C. elegans as a single heterochronic factor controlling developmental timing[1, 2]. Since then, this family of miRNAs has been shown to play somewhat equivalent roles in all bilaterian organisms, and the let-7s were the first miRNAs identified in humans[1, 3]. The let-7s have now been implicated in differentiation and maturation of many tissues during development in vivo and in vitro[4-7]3–8. As with other miRNAs, the initial pri-let-7 transcripts are first transcribed by RNA polymerase II, then processed via the canonical pathway through the pre-miRNA stage generated by the action of Drosha/DGCR8. The pre-miRNA is then processed in the cytoplasm by Dicer to generate the mature version of the miRNA[8-10]. In addition, in the case of let-7 miRNAs, other processes such as uridylation are used to stabilize or destabilize miRNAs[11-13]. LIN28A and LIN28B are RNA binding proteins that regulate several of these processing steps to control levels of mature let-7 transcripts[14, 15]. Over evolution, let-7 isoforms have expanded such that the human genome contains 9 isoforms. The study of regulation of the let-7 family of miRNAs has focused on these processing steps, but less is understood about how the pri-let-7 transcripts are regulated by transcription prior to any processing. Studies in C. elegans, where the activity and expression of let-7 is regionally and temporally constrained, have attempted to clarify transcriptional regulation from the single let-7 locus. Two regulatory regions upstream of the locus were identified as the temporally regulated expression binding site (TREB) and the let-7 transcription element (LTE), and many studies have tested the binding and transcriptional control exerted by several TFs including elt-1 and daf-12[2, 16–18]. These sequences are not present upstream of mammalian let-7 gene, and there are not similarly consistently present sequences near all the different let-7 loci. In higher organisms, a different system for regulating let-7 miRNA transcription must have been established. The study of mammalian pri-let-7 transcription is hampered by the relative scarcity of the transcript which is processed immediately in the nucleus and therefore difficult to detect. We previously took advantage of a method that allows for the capture of nascent RNA transcripts, which are still associated with the chromatin from which they are transcribed, to carefully annotate pri-let-7 transcripts[19, 20]. Another group later induced pri-let-7 accumulation in the context of DGCR8 knockout, and validated with RACE PCR that primary let-7 transcripts have multiple isoforms, some of which aligned nearly identically to our observed annotation patterns and varied in different cellular contexts[21]. From these annotations, it is clear that many let-7 family members are transcribed within very long (up to 200KB), often polycistronic transcripts[20, 21]. While some studies have identified transcriptional models of pri-miRNAs in higher organisms, the lack of proper annotation left the precise regulatory motifs for human let-7 transcripts undefined. Here, after complete annotation of let-7 transcripts, we attempt to define regulatory motifs for this family of miRNAs by taking advantage of Chromatin-associated RNA-seq and the latest genomic descriptions of chromatin states within let-7 loci. We model let-7 transcription in distinct neural paradigms to reveal subsets of let-7 family members that are transcribed constitutively versus dynamically regulated in particular contexts. Finally, by analyzing publically available data for let-7 loci, we identify transcription factors that appear to regulate let-7 transcription by acting at either promoter or enhancer elements enriched in dynamically regulated let-7 polycistrons.

Results

Identification of dynamics of let-7 polycistron transcription

As a first step to determine how let-7 miRNAs are transcriptionally regulated, we attempted to define developmental models that display dynamism of transcription. We previously identified dynamic transcriptional regulation of some let-7 family members between neural progenitors that represent distinct developmental stages[20]. This developmental system has been described in our previous studies[19, 20, 22], and has become routine in the field. Initially, human pluripotent stem cells are directed towards a neural fate by changing the media. Then, as neural rosettes are formed, they are manually isolated and expanded in neural proliferation media containing EGF and FGF. To further differentiate towards later lineages, we used growth factor withdrawal, where EGF and FGF are removed and the neural progenitors are forced to differentiate towards neurons and glia. We validated the identity of cells generated at each step by immunostaining for markers typical of each stage of specification (pluripotent: OCT4/NANOG, NPC: SOX2, SOX1, Neuron: MAP2, TuJ1), and consider the culture to be suitable homogenous if the cells are at least 90% positive for combinations of markers. We previously showed that pri-let-7 transcripts can be identified by Chromatin-associated RNA-seq data[20](NIH GEO Dataset GSE32916). This method captures RNA still associated with chromatin, and therefore represents nascent messages[23]. Our previous analysis initially predicted that some pri-let-7s could be dynamically regulated, so we extended these analyses here. Here we show that there is dynamism of let-7 transcription as measured by Chromatin-associated RNA-seq as witnessed by the fact that the let-7a3/b locus is practically silent in pluripotent stem cells, and neural progenitors derived therein, but strongly expressed in tissue derived neural progenitors (Fig 1A). This is consistent with the idea that tissue derived progenitors represent a later stage of development than pluripotent derived progenitors[19, 20].
Fig 1

Dynamic transcriptional regulation of some pri-let-7 transcripts.

Chromatin-associated RNA-seq reads were mapped onto two distinct polycistronic let-7 loci. At left, the let-7a3/b locus, is dynamic, while at right, the let-7a1/d/f1 locus, is constitutively expressed. Reads are shown for ESC, iPSC, PSC-derived NPC, and neural tissue-derived NPC stages. These reads are aligned with validated primary miRNA transcripts from RACE PCR experiments in green and RefSeq annotated genes in blue25. Note that Chromatin-associated RNA-seq and RACE PCR annotated transcripts demonstrate the existence of longer transcripts from different transcriptional start sites than suggested by the RefSeq annotation. In the case of let-7a1/d/f1, this discrepancy extends to the strand from which initial transcription occurs.

Dynamic transcriptional regulation of some pri-let-7 transcripts.

Chromatin-associated RNA-seq reads were mapped onto two distinct polycistronic let-7 loci. At left, the let-7a3/b locus, is dynamic, while at right, the let-7a1/d/f1 locus, is constitutively expressed. Reads are shown for ESC, iPSC, PSC-derived NPC, and neural tissue-derived NPC stages. These reads are aligned with validated primary miRNA transcripts from RACE PCR experiments in green and RefSeq annotated genes in blue25. Note that Chromatin-associated RNA-seq and RACE PCR annotated transcripts demonstrate the existence of longer transcripts from different transcriptional start sites than suggested by the RefSeq annotation. In the case of let-7a1/d/f1, this discrepancy extends to the strand from which initial transcription occurs. On the other hand, the same analysis for the let-7a1/d/f1 locus showed that this polycistron is constitutively expressed across all cell types assayed (Fig 1B). Furthermore, Chromatin-associated RNA-seq also allows for mapping reads which highlighted the fact that let-7 transcripts are long and sometimes polycistronic. Finally, this allowed for proper annotation of these polycistronic transcripts by actual measurement of message as opposed to the RefSeq annotations that were performed by localizing epigenetic markers. In so doing, we find that the RefSeq annotations underestimate the length of the let-7 polycistrons. The annotations resulting from the Chromatin-associated RNA-seq are then highly overlapping with those in another study, Chang et al[21]. A complete presentation of transcriptional data from the other let-7 loci as demonstrated by Chromatin-RNA-seq is in (S1 Fig). Using RNA from cultures previously described [20], we performed Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) to show that as human pluripotent stem cells are specified to neural progenitors, and subsequently into neurons, some primary let-7 transcripts are strongly induced as measured by RT-PCR (Fig 2). Because pri-miRNAs are transcribed as longer messages, they can be specifically identified by designing at least one of the PCR primers to recognize strictly cDNA made from the portions of the pri-miRNA message not found in pre-mrRNA or mature miRNA. In both developmental scenarios, we observed that a subset of let-7 family members showed transcriptional induction over developmental time, while other members appeared to be constitutively transcribed (Fig 2A). Using primers that recognize the mature version of miRNA, RNA isolated in a manner that enriches for small RNA, and a specialized cDNA synthesis kit (miScript) we also specifically analyzed levels of mature let-7s. We found that the levels of all mature let-7 family members were strongly induced across development (Fig 2B).
Fig 2

Expression of pri-let-7 during neural specification.

Pluripotent stem cells were differentiated through the neural lineage to neural progenitor cells (NPCs) and then to neurons. Using RT-PCR with primers specific to the let-7 miRNAs at different stages of processing, we tested changes in expression of the pri-let-7s (A) and their mature forms (B). While all mature miRNAs increased over the course of differentiation, only a subset (marked with dotted lines), the dynamically regulated let-7s, also increased before processing, at the primary let-7 stage. RT-PCRs were also performed beginning with ES cells. (C) Graphic comparing the length of the RefSeq annotated let-7a3/b with our predicted transcript. Stars mark primer pairs for RT-PCR along the full transcript. (D) RT-PCR of pri-let-7a3/b transcript in tissue-derived NPCs, in which transcription is abundant. In control, siDGCR8 (to block Microprocessor function and pri-to-pre conversion), and siDICER (to block pre-to-mature conversion) conditions. When Microprocessor is disabled, the entire let-7a3/b transcript accumulates.

Expression of pri-let-7 during neural specification.

Pluripotent stem cells were differentiated through the neural lineage to neural progenitor cells (NPCs) and then to neurons. Using RT-PCR with primers specific to the let-7 miRNAs at different stages of processing, we tested changes in expression of the pri-let-7s (A) and their mature forms (B). While all mature miRNAs increased over the course of differentiation, only a subset (marked with dotted lines), the dynamically regulated let-7s, also increased before processing, at the primary let-7 stage. RT-PCRs were also performed beginning with ES cells. (C) Graphic comparing the length of the RefSeq annotated let-7a3/b with our predicted transcript. Stars mark primer pairs for RT-PCR along the full transcript. (D) RT-PCR of pri-let-7a3/b transcript in tissue-derived NPCs, in which transcription is abundant. In control, siDGCR8 (to block Microprocessor function and pri-to-pre conversion), and siDICER (to block pre-to-mature conversion) conditions. When Microprocessor is disabled, the entire let-7a3/b transcript accumulates. As evidence for the long length of these transcripts, RT-PCR was performed using primers that recognize different regions of the predicted transcript from the let-7a3/b locus (Fig 2C). In addition, we posited that this transcript would accumulate in abundance if downstream processing by DGCR8 was inhibited. siRNA-mediated silencing of DGCR8 increased levels of the let-7a3/b transcript as measured by all the primers across the entire predicted polycistron. Silencing of DICER, necessary for the final step of miRNA processing, did not change the level of any portion of the let-7a3/b transcript (Fig 2D). As further evidence that let-7 transcripts are polycistronic, the data in Fig 1A and 1B on dynamic versus constitutive indeed showed a shared pattern for those let-7s that are in the same polycistron. For instance, the pattern of let-7a and let-7b was conserved and dynamic in both contexts, while let-7a1, let-7d and let-7f1, which are also polycistronically transcribed, were constitutively expressed in both contexts.

Identification of potential epigenetic regulation of let-7 polycistrons

We then sought to determine whether the dynamic versus constitutive let-7 polycistrons display distinct regulatory schemes. Using data from the Epigenetic Roadmap, we annotated the chromatin states across each polycistronic let-7 locus (Fig 3 and S2 Fig). The Roadmap database includes data from dozens of human cell types, including several of the neural lineage and pluripotent stem cells, both highly relevant to our current study[24, 25]. This analysis showed a clear distinction between the regulatory framework for the dynamically regulated let-7a3/b locus, versus that of the constitutively expressed let-7a1/let-7d/let-7f1locus. The clearest distinction comes in the form of location of epigenetic marks for enhancers and transcriptional start sites (TSSs), where the let-7a3/b locus contains several possible start sites and putative enhancers, while the let-7a1/let-7d/let-7f1 locus appears to only have one predicted start site and regulatory scheme. We posit that having multiple possible TSSs could indicate a message that is dynamically regulated in a variety of settings.
Fig 3

Dynamically and constitutively transcribed let-7 loci show distinct epigenetic signatures.

Computationally imputed chromatin states generated by the ChromHMM algorithm at the same let-7 loci. Each row represents one biological sample. These states show active transcriptional marks at the predicted TSS for let-7a1/d/f1 in multiple cell types. At the let-7a3/b locus, ES cells, iPS cells, and PSC-derived NPCs have marks consistent with poised promoters, but later in differentiation active TSS marks appear at the same sites, reflecting changes in epigenetic state during neural differentiation. Epigenetic marks in K562 leukemia cells show active transcription at the RefSeq annotated let-7a3/b locus.

Dynamically and constitutively transcribed let-7 loci show distinct epigenetic signatures.

Computationally imputed chromatin states generated by the ChromHMM algorithm at the same let-7 loci. Each row represents one biological sample. These states show active transcriptional marks at the predicted TSS for let-7a1/d/f1 in multiple cell types. At the let-7a3/b locus, ES cells, iPS cells, and PSC-derived NPCs have marks consistent with poised promoters, but later in differentiation active TSS marks appear at the same sites, reflecting changes in epigenetic state during neural differentiation. Epigenetic marks in K562 leukemia cells show active transcription at the RefSeq annotated let-7a3/b locus. Using these data and the imputed chromatin state model in tamed, we clearly identified TSSs, promoters (active and poised), enhancers, and actively transcribed regions for two of the let-7 polycistrons (Fig 3). As further evidence for their polycistronic nature, these updated epigenetic data from a wide variety of primary cell types again predicted single, long transcripts across entire loci that encompass multiple let-7 family members, as opposed to older analyses on transformed cell lines upon which the RefSeq annotations were created. Importantly, some of the genomic state models predicted variation of states in distinct cell types. Notably, the predicted promoter of let-7a3/b was shown to be poised in hPSCs and hPSC-derived NPCs, and active and transcribed in later neural derivatives and in brain. This pattern is highly consistent with our own transcriptional data whereby the pri-let-7a3/b polycistron was not transcribed significantly until hPSC-derived NPCs were driven further to neurons (Fig 2A and 2B).

Functionally defining regulators of let-7 transcription

Globally, the utility of these analyses was to define more precisely the location of promoters and enhancers for each of the pri-let-7s. Taking advantage of the annotation of promoters, we attempted to identify mechanisms of transcriptional regulation of the dynamic versus constitutively regulated let-7 polycistrons. With a focus on let-7a3/b, we searched for transcription factors that could regulate this polycistron through interactions at the promoter. We first used transcription factor ChIP-Seq data from the ENCODE and the Epigenetic Roadmap datasets to detect transcription factor binding sites enriched in this promoter (Fig 4A). We then narrowed the list of candidates to include just those whose expression changes in contexts where let-7a3/b transcription also changes. This led to the identification of 10 TFs as defined by previous data showing their ability to both bind DNA and affect transcription of target genes (Fig 4B). To functionally determine whether any of these TFs can affect let-7a3/b transcription, we silenced some of them in tissue-NPCs (where transcription of let-7a3/b is high) and performed RT-PCR. In addition, we also targeted MYCN as a positive control because of its previously established ability to regulate let-7 transcription [1, 26, 27] and based on its expression pattern in our neurodevelopmental model. Silencing of N-MYC, AP2a, or EGR1 all appeared to lead to an increase in let-7a3/b transcription after just two days (Fig 4C and 4D), indicating a role for these TFs in transcriptional regulation of this polycistron.
Fig 4

Transcription factors predicted to bind to the let-7a3/b promoter regulate primary let-7a3/b transcription.

(A) Comparison of transcription factors with experimentally determined binding sites to the bona fide let-7a3/b promoter from the ENCODE database with genes differentially expressed between tissue-derived NPCs (in which let-7a3/b is abundantly transcribed) and PSC-derived NPCs (in which it is not). 10 genes were present in both sets, and are shown at right, ranked by their fold change of expression between tissue-derived and PSC-derived NPCs from microarray based gene expression measurements. We knocked down several of these candidate let-7 regulator transcription factors in tissue-derived NPCs. (B) Knockdown of the TFAP2C gene encoding the AP-2γ protein, and of the MYCN gene increase transcription of several let-7 genes. Data shown are representative of 3 independent experiments. (C) Knockdown of EGR1 increases transcription of primary let-7b and other let-7 genes. Error bars are ± SEM from n = 3 biological replicates.

Transcription factors predicted to bind to the let-7a3/b promoter regulate primary let-7a3/b transcription.

(A) Comparison of transcription factors with experimentally determined binding sites to the bona fide let-7a3/b promoter from the ENCODE database with genes differentially expressed between tissue-derived NPCs (in which let-7a3/b is abundantly transcribed) and PSC-derived NPCs (in which it is not). 10 genes were present in both sets, and are shown at right, ranked by their fold change of expression between tissue-derived and PSC-derived NPCs from microarray based gene expression measurements. We knocked down several of these candidate let-7 regulator transcription factors in tissue-derived NPCs. (B) Knockdown of the TFAP2C gene encoding the AP-2γ protein, and of the MYCN gene increase transcription of several let-7 genes. Data shown are representative of 3 independent experiments. (C) Knockdown of EGR1 increases transcription of primary let-7b and other let-7 genes. Error bars are ± SEM from n = 3 biological replicates. To focus on potential regulatory mechanisms at enhancers, we next looked for putative enhancers by looking for regions of enriched DNAse-hypersensitivity, peaks of H3K27ac, and peaks associated with p300 binding in the let-7a3/b locus (Fig 5A). Several predicted enhancers, outlined in red rectangles, were highly DNAse sensitive region in Fetal and Adult brain samples but not in PSCs or PSC-derived NPCs. This pattern correlates with the timing of increased pri-let7a3/b transcription. A different site, 10kb upstream of the newly annotated TSS, is outlined in a green rectangle, and instead showed DNAse sensitivity only in PSC-derived NPCs, and not in either the undifferentiated or fully differentiated cells in the database. All of these identified regions showed P300 binding, were surrounded by ChIP-seq peaks for acetylated H3K27 in neural samples, and were significant for a specific depletion of histone-associated ChIP-seq binding peaks right at the site of DNAse sensitivity.
Fig 5

FOX proteins are predicted to bind to putative let-7a3/b enhancer regions.

(A) The predicted existence of an upstream enhancer for the let-7a3/b locus was based on the epigenetic state at a region 10kb upstream of the TSS, outlined in green. In addition to being marked by H3K27Ac ChIP-Seq peaks with a localized dip in signal intensity, and peaks for the enhancer-associated histone acetyltransferase protein P300, this region showed dynamic changes in DNAse sensitivity. Note that a large DNAse sensitivity peak appears only in ES-derived NPCs, suggesting a differentiation state-specific chromatin opening at this region. At bottom, relative intensity of forkhead box protein ChIP-Seq from multiple cell types are pooled, with the darkest regions indicating intense FOX protein binding. Outlined in red are similar regions that show DNAse sensitivity beginning at the fetal brain stage that also colocalize with FOX protein binding. (B) A zoomed in view of the green region of increased DNAse sensitivity in PSC-derived NPCs. In blue are computationally predicted transcription factor binding sites from the ORCAtk database. The degree of genomic conservation along this region from the PhastCons64 database is shown in purple. At bottom are transcription factor ChIP-seq mapped peaks from the ENCODE database. The regions in green mark forkhead box transcription factor conserved motifs. Note that the forkhead box motifs co-localize with a region of highly conserved sequence, and the redundant binding of the forkhead box motif by many family members predicts that many such proteins can bind there.

FOX proteins are predicted to bind to putative let-7a3/b enhancer regions.

(A) The predicted existence of an upstream enhancer for the let-7a3/b locus was based on the epigenetic state at a region 10kb upstream of the TSS, outlined in green. In addition to being marked by H3K27Ac ChIP-Seq peaks with a localized dip in signal intensity, and peaks for the enhancer-associated histone acetyltransferase protein P300, this region showed dynamic changes in DNAse sensitivity. Note that a large DNAse sensitivity peak appears only in ES-derived NPCs, suggesting a differentiation state-specific chromatin opening at this region. At bottom, relative intensity of forkhead box protein ChIP-Seq from multiple cell types are pooled, with the darkest regions indicating intense FOX protein binding. Outlined in red are similar regions that show DNAse sensitivity beginning at the fetal brain stage that also colocalize with FOX protein binding. (B) A zoomed in view of the green region of increased DNAse sensitivity in PSC-derived NPCs. In blue are computationally predicted transcription factor binding sites from the ORCAtk database. The degree of genomic conservation along this region from the PhastCons64 database is shown in purple. At bottom are transcription factor ChIP-seq mapped peaks from the ENCODE database. The regions in green mark forkhead box transcription factor conserved motifs. Note that the forkhead box motifs co-localize with a region of highly conserved sequence, and the redundant binding of the forkhead box motif by many family members predicts that many such proteins can bind there. We used a similar approach to identify predicted and validated TF binding sites in the enhancer regions as on promoter sequences (Fig 5B). This analysis yielded a strong enrichment of binding by the forkhead box transcription factors (FOX proteins), all of which can bind the same motif: 5'-[AC]A[AT]T[AG]TT[GT][AG][CT]T[CT]-3'[28]. Note the increased intensity of FOX protein ChIP-seq signal within the putative enhancers in Fig 5A. The furthest upstream such region, outlined in green, is shown in more detail, with both predicted and experimental FOX protein binding localizing to one highly conserved area (Fig 5B). The forkhead box TFs contain winged helix domains, which contribute to the pioneer transcription factor activity of the entire family and in some settings could be responsible for observed changes in chromatin accessibility[29-32]. We compared this finding with expression data to subsequently determine which candidate forkhead box TFs could potentially be acting at the let-7a3/b enhancer during neural development (Fig 5B). The forkhead box proteins FOXP2, FOXP1, FOXP4, FOXN2, FOXN3, FOXN4, and FOXG1 showed both high baseline expression and dynamic changes in expression over the course of nervous system development (Fig 6A). FOXP2’s role in brain development is linked closely to its involvement in diseases of speech and language[33, 34]. In the murine developing spinal cord and cortex, Foxp2 and Foxp4 are expressed in neural progenitor cells and increase in abundance during neuronal differentiation[33]. In Foxp4-/- mice, these NPCs fail to exit the progenitor stage and cause major disruptions in the developing neural tube. No function in the nervous system has been ascribed to either FOXN2 or FOXN3, but murine Foxn4 is expressed in the brain and retina, and is necessary for the specification of retinal amacrine cells[35]. Taken together, forkhead box proteins have the molecular components necessary to induce reorganizations of the epigenetic state, and some are expressed at anatomic locations and times that correlate with let-7 expression.
Fig 6

A role for FOX proteins in regulation of pri-let-7s.

(A) By filtering for FOX genes that are actively transcribed in our neural cells and differentially expressed between PSC-derived NPCs and Tissue-derived NPCs, we generated a list of candidate proteins that might mediate changes in let-7a3/b transcription. (B) Knockdown of FOX proteins, FOXP2, FOXP4 and FOXN3 in Tissue-derived NPCs show distinct effects on primary let-7 transcript levels. Statistics were performed across three independent experiments (two-tailed t-test, p < 0.05).

A role for FOX proteins in regulation of pri-let-7s.

(A) By filtering for FOX genes that are actively transcribed in our neural cells and differentially expressed between PSC-derived NPCs and Tissue-derived NPCs, we generated a list of candidate proteins that might mediate changes in let-7a3/b transcription. (B) Knockdown of FOX proteins, FOXP2, FOXP4 and FOXN3 in Tissue-derived NPCs show distinct effects on primary let-7 transcript levels. Statistics were performed across three independent experiments (two-tailed t-test, p < 0.05). FOXP2, FOXP4, and FOXN3 are all suppressed over the course of our neurodevelopmental model (Fig 6A). Silencing either FOXP4 or FOXP2 in human neural progenitors appeared to inhibit expression of the let-7a3/b, let-7e and let-7i loci, while having nearly the opposite effect on the let-7a1/d/f1 and let7c loci (Fig 6B). On the other hand, silencing FOXN3 did not affect let-7a3b, but did induce let-7c and let-7e (Fig 6B). The fact that the polycistronic let-7 pri-miRNAs appeared to be regulated in concert as a result of these manipulations is further evidence of the co-regulatory mechanisms used during cell fate decision-making. Together, these data demonstrate that proper annotation of let7 loci can facilitate prediction of regulatory elements that are bound by transcription factors with the ability to regulate let-7 transcription.

Discussion

Together, these analyses define contexts in which particular let-7 polycistrons are transcriptionally regulated, and identify TFs that play roles in this dynamism. This study is not the first to identify transcriptional mechanisms for let-7 family members, but previous studies from lower organisms did not take advantage of genome-wide analyses to systematically define regulatory modules or transcription factors that regulate them. The fact that let-7 miRNAs can be dynamically regulated at the transcriptional level has only recently been appreciated, but the relative contribution of this regulation relative to levels of mature let-7s remains undefined. This is potentially an important issue to resolve as recent evidence suggests that not all let-7 miRNAs are processed by the same machinery[36], and therefore, the level of mature let-7 might not simply be DICER dependent. These issues bring to light an interesting question, why have mammals evolved to have so many let-7 isoforms in their genomes, and why do so in polycistronic fashion. Because all the let-7 family members have the same seed sequence, it seems redundant to express so many. Even in the early neural lineage where mature let-7s are scarce, some of the let-7 polycistrons are not transcribed, whereas others appear to be constitutively expressed. While we can only speculate, it is possible that both dynamic and constitutive let-7 transcription is a function of feed-back activity of let-7-target interactions. It is worth pointing out that some let-7 targets also regulate let-7 maturation, such as LIN28A, LIN28B and LIN41. Furthermore, it has been proposed that some let-7 target RNAs can act as ceRNA or sponges of mature let-7 to regulate their activity[37]. In addition, some of the TFs shown here and elsewhere to regulate let-7 transcription (e.g. N-MYC) are also let-7 target genes[27, 38, 39]. Perhaps, the constitutive transcription and maturation of small amounts of let-7 serves as something of a rheostat of developmental timing that is tuned as cells become more specified, leading to changes in let-7 targeted TFs that can then in turn regulate let-7 transcription, leading to even more mature let-7 through an additional feed-forward mechanism. In C. elegans, where let-7s were first discovered, there is evidence for both transcriptional and maturation control despite the fact that all let-7 is transcribed from a single locus. In fact, there are two distinct transcriptional start sites and these are distinctly regulated by both cis and trans mechanisms. There is further evidence that let-7s play a more general role in miRNA biogenesis through an interaction with Argonaute[40, 41]. Therefore, sophisticated mechanisms for let-7 regulation have been preserved and expanded across evolution, perhaps pointing to their critical roles in both developmental timing and tumorigenesis. These issues are highly relevant to the study of cancer, where let-7 targets are strongly induced, consistent with a loss of mature let-7. It is possible that transcriptional induction of let-7 family members could be a strategy to drive a cascade of re-expression of let-7 in cancerous tissues, akin to the process which appears to happen during early human development.

Materials and Methods

Cell culture

Pluripotent stem cell culture and differentiation into NPCs and neurons was performed as previously described6. Briefly, PSCs were induced to differentiate along the neuroepithelial lineage by treatment with dual inhibitors of the SMAD signaling pathway, SB431542 (Sigma, 5 μM) and LDN193189 (Sigma, 50 nM). Neuroepithelial rosettes were manually picked and replated onto plates coated with ornithine and laminin. Cells were maintained and expanded in NPC media, containing DMEM/F-12 (Gibco), B27 supplement (Gibco), N2 (Gibco), EGF and bFGF. To induce differentiation, cells were fed with media lacking EGF and bFGF for 3 weeks. Tissue-derived NPCs were cultured and differentiated with the same reagents6.

siRNA transfection

Gene knockdowns were performed by transfecting cells with double stranded 27mer RNAs (OriGene) using the lipofectamine RNAiMAX reagent (Thermo Fisher) according to the protocol provided.

Measurements of gene expression by RT-PCR

Cells were lysed in Trizol lysis reagent (Thermo Fisher), and total RNA was purified from lysates using the QIAgen miRNeasy kit. cDNA was made by reverse transcription from mRNAs with the SuperScript III First Strand Synthesis system (Thermo Fisher), or from miRNAs with the miScript II RT Kit (Qiagen). Realtime PCR was performed on a Roche Lightcycler 480 instrument. For mRNA-derived cDNA, Roche 480 SYBR green I was used. For miRNA-derived cDNA, miScript SYBR (Qiagen) was used. To calculate relative amounts of transcripts, the Real-time data were calculated based on expression levels of housekeeping genes (GAPDH for mRNAs; U6 for miRNAs). miR-15 was included as a control in RT-PCR experiments as this has been proposed to be constitutively expressed in a variety of settings.

Epigenome characterization and candidate TF prediction

Summary ENCODE and Roadmap gene expression data, ChIP-Seq mapping data, and ChromHMM chromatin state prediction were accessed and visualized using the UCSC genome browser and the WashU Epigenome Browser43,44. These tools were also used to import and visualize Chromatin-associated RNA-seq reads from Patterson et al. and miRNA gene transcripts in cells lacking DGCR8 from Chang et al6,25.Transcription factor binding site predictions were performed with the ORCA Toolkit web server, and with the MEME suite of motif analysis applications45,46.

Expanded method

The ENCODE and Epigenetic Roadmap datasets, with accession numbers listed in Tables 1 and 2, contain mapped reads from various gene expression and ChIP-sequencing experiments performed on a panel of cell lines and cell types isolated from primary human tissue. These datasets were accessed and imported using the These datasets were accessed and imported using the UCSC genome browser and the WashU Epigenome Browser to co-register and visualize enrichment of epigenetic characteristics across the genome. In figures utilizing Roadmap expression data, track intensity is a logarithmic graph of p-value signal.
Table 1

Data from Roadmap project in GEO database.

# GEO AccessionSample NameExperiment
GSM772769brain, angular gyrusH3K4me3
GSM772770brain, angular gyrusH3K4me1
GSM772779brain, angular gyrusH3K9me3
GSM772959brain, angular gyrusH3K4me3
GSM772960brain, angular gyrusH3K9me3
GSM772962brain, angular gyrusH3K4me1
GSM772983brain, angular gyrusH3K27me3
GSM773016brain, angular gyrusH3K27ac
GSM1112807brain, angular gyrusH3K27ac
GSM669915brain, anterior caudateH3K27me3
GSM669970brain, anterior caudateH3K4me1
GSM669994brain, anterior caudateH3K9me3
GSM670031brain, anterior caudateH3K4me3
GSM772827brain, anterior caudateH3K27me3
GSM772829brain, anterior caudateH3K4me3
GSM772830brain, anterior caudateH3K4me1
GSM772831brain, anterior caudateH3K9me3
GSM772832brain, anterior caudateH3K27ac
GSM1112811brain, anterior caudateH3K27ac
GSM669905brain, cingulate gyrusH3K4me3
GSM669923brain, cingulate gyrusH3K9me3
GSM670033brain, cingulate gyrusH3K4me1
GSM772989brain, cingulate gyrusH3K27me3
GSM773007brain, cingulate gyrusH3K4me1
GSM773008brain, cingulate gyrusH3K4me3
GSM773011brain, cingulate gyrusH3K27ac
GSM916023brain, cingulate gyrusH3K9me3
GSM1112813brain, cingulate gyrusH3K27ac
GSM669624brain, dorsal neocortex, fetal week15 UH3K4me3
GSM669625brain, dorsal neocortex, fetal week15 UH3K27me3
GSM878650brain, fetal day101 MDNase hypersensitivity
GSM878651brain, fetal day104 MDNase hypersensitivity
GSM1027328brain, fetal day105 MDNase hypersensitivity
GSM878652brain, fetal day109 FDNase hypersensitivity
GSM665804brain, fetal day112 UDNase hypersensitivity
GSM595920brain, fetal day117 FDNase hypersensitivity
GSM706850brain, fetal day120 UH3K4me1
GSM916054brain, fetal day120 UH3K9me3
GSM916061brain, fetal day120 UH3K27me3
GSM530651brain, fetal day122 MDNase hypersensitivity
GSM595913brain, fetal day122 MDNase hypersensitivity
GSM621393brain, fetal day122 MH3K27me3
GSM621427brain, fetal day122 MH3K9me3
GSM621457brain, fetal day122 MH3K4me3
GSM665819brain, fetal day142 FDNase hypersensitivity
GSM595922brain, fetal day85 FDNase hypersensitivity
GSM595923brain, fetal day85 FDNase hypersensitivity
GSM595926brain, fetal day96 FDNase hypersensitivity
GSM595928brain, fetal day96 FDNase hypersensitivity
GSM806934brain, fetal week17 FH3K4me1
GSM806935brain, fetal week17 FH3K4me3
GSM806936brain, fetal week17 FH3K9me3
GSM806937brain, fetal week17 FH3K27me3
GSM806942brain, fetal week17 FH3K4me1
GSM806943brain, fetal week17 FH3K4me3
GSM806944brain, fetal week17 FH3K9me3
GSM806945brain, fetal week17 FH3K27me3
GSM706999brain, germinal matrix, fetal week20 MH3K4me3
GSM707000brain, germinal matrix, fetal week20 MH3K9me3
GSM707001brain, germinal matrix, fetal week20 MH3K27me3
GSM806939brain, germinal matrix, fetal week20 MH3K4me1
GSM806940brain, germinal matrix, fetal week20 MH3K4me3
GSM806941brain, germinal matrix, fetal week20 MH3K9me3
GSM817226brain, germinal matrix, fetal week20 MH3K27me3
GSM817228brain, germinal matrix, fetal week20 MH3K4me1
GSM669913brain, hippocampus middleH3K27me3
GSM669962brain, hippocampus middleH3K4me1
GSM670001brain, hippocampus middleH3K9me3
GSM670022brain, hippocampus middleH3K4me3
GSM773017brain, hippocampus middleH3K9me3
GSM773020brain, hippocampus middleH3K27ac
GSM773021brain, hippocampus middleH3K4me1
GSM773022brain, hippocampus middleH3K4me3
GSM916034brain, hippocampus middleH3K9me3
GSM916035brain, hippocampus middleH3K27ac
GSM916038brain, hippocampus middleH3K27me3
GSM916039brain, hippocampus middleH3K4me1
GSM916040brain, hippocampus middleH3K4me3
GSM1112791brain, hippocampus middleH3K27ac
GSM1112800brain, hippocampus middleH3K27me3
GSM669992brain, inferior temporal lobeH3K4me3
GSM670005brain, inferior temporal lobeH3K9me3
GSM670036brain, inferior temporal lobeH3K4me1
GSM772772brain, inferior temporal lobeH3K27me3
GSM772992brain, inferior temporal lobeH3K4me1
GSM772993brain, inferior temporal lobeH3K27me3
GSM772994brain, inferior temporal lobeH3K9me3
GSM772995brain, inferior temporal lobeH3K27ac
GSM772996brain, inferior temporal lobeH3K4me3
GSM1112812brain, inferior temporal lobeH3K27ac
GSM669965brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K9me3
GSM670015brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K4me1
GSM670016brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K4me3
GSM772833brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K27me3
GSM772834brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K9me3
GSM773012brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K4me3
GSM773014brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K4me1
GSM773015brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K27ac
GSM1112810brain, mid frontal, Brodmann area 9/46, dorsolateral prefrontal cortexH3K27ac
GSM669941brain, substantia nigraH3K4me1
GSM669953brain, substantia nigraH3K27me3
GSM669973brain, substantia nigraH3K9me3
GSM670038brain, substantia nigraH3K4me3
GSM772897brain, substantia nigraH3K9me3
GSM772898brain, substantia nigraH3K4me1
GSM772901brain, substantia nigraH3K4me3
GSM772937brain, substantia nigraH3K27me3
GSM997258brain, substantia nigraH3K27ac
GSM1112778brain, substantia nigraH3K27ac
GSM537625ES-I3 cell lineH3K9me3
GSM537626ES-I3 cell lineH3K4me3
GSM537627ES-I3 cell lineH3K27me3
GSM537648ES-I3 cell lineH3K27me3
GSM537664ES-I3 cell lineH3K9me3
GSM537665ES-I3 cell lineH3K4me3
GSM537668ES-I3 cell lineH3K4me1
GSM772789ES-I3 cell lineH3K4me1
GSM537623ES-WA7 cell lineH3K4me3
GSM537639ES-WA7 cell lineH3K9me3
GSM537641ES-WA7 cell lineH3K4me1
GSM537657ES-WA7 cell lineH3K27me3
GSM409307H1 cell lineH3K4me1
GSM409308H1 cell lineH3K4me3
GSM410808H1 cell lineH3K4me3
GSM428291H1 cell lineH3K9me3
GSM428295H1 cell lineH3K27me3
GSM432392H1 cell lineH3K4me3
GSM433167H1 cell lineH3K27me3
GSM433170H1 cell lineH3K4me3
GSM433174H1 cell lineH3K9me3
GSM433177H1 cell lineH3K4me1
GSM434762H1 cell lineH3K4me1
GSM434776H1 cell lineH3K27me3
GSM450266H1 cell lineH3K9me3
GSM466732H1 cell lineH3K27ac
GSM466734H1 cell lineH3K27me3
GSM466739H1 cell lineH3K4me1
GSM469971H1 cell lineH3K4me3
GSM537679H1 cell lineH3K4me1
GSM537680H1 cell lineH3K4me3
GSM537681H1 cell lineH3K4me3
GSM537683H1 cell lineH3K27me3
GSM605308H1 cell lineH3K27me3
GSM605312H1 cell lineH3K4me1
GSM605315H1 cell lineH3K4me3
GSM605325H1 cell lineH3K9me3
GSM605327H1 cell lineH3K9me3
GSM605328H1 cell lineH3K9me3
GSM663427H1 cell lineH3K27ac
GSM818057H1 cell lineH3K9me3
GSM878616H1 cell lineDNase hypersensitivity
GSM878621H1 cell lineDNase hypersensitivity
GSM1185386H1 cell lineH3K27me3
GSM753429H1 derived neuronal progenitor cultured cellsH3K27ac
GSM767343H1 derived neuronal progenitor cultured cellsH3K27ac
GSM767350H1 derived neuronal progenitor cultured cellsH3K4me3
GSM767351H1 derived neuronal progenitor cultured cellsH3K4me3
GSM818031H1 derived neuronal progenitor cultured cellsH3K27ac
GSM818032H1 derived neuronal progenitor cultured cellsH3K27me3
GSM818033H1 derived neuronal progenitor cultured cellsH3K27me3
GSM818039H1 derived neuronal progenitor cultured cellsH3K4me1
GSM818040H1 derived neuronal progenitor cultured cellsH3K4me1
GSM818043H1 derived neuronal progenitor cultured cellsH3K4me3
GSM818055H1 derived neuronal progenitor cultured cellsH3K9me3
GSM818056H1 derived neuronal progenitor cultured cellsH3K9me3
GSM878615H1 derived neuronal progenitor cultured cellsDNase hypersensitivity
GSM896162H1 derived neuronal progenitor cultured cellsH3K27ac
GSM896165H1 derived neuronal progenitor cultured cellsH3K27me3
GSM906379H1 derived neuronal progenitor cultured cellsDNase hypersensitivity
GSM956008H1 derived neuronal progenitor cultured cellsH3K27ac
GSM956010H1 derived neuronal progenitor cultured cellsH3K27me3
GSM1013146H1 derived neuronal progenitor cultured cellsH3K4me1
GSM1013151H1 derived neuronal progenitor cultured cellsH3K4me3
GSM1013158H1 derived neuronal progenitor cultured cellsH3K9me3
GSM605307H9 cell lineH3K27ac
GSM605316H9 cell lineH3K4me3
GSM616128H9 cell lineH3K4me3
GSM665037H9 cell lineH3K27ac
GSM667622H9 cell lineH3K27me3
GSM667626H9 cell lineH3K4me1
GSM667631H9 cell lineH3K9me3
GSM667632H9 cell lineH3K9me3
GSM667633H9 cell lineH3K9me3
GSM706066H9 cell lineH3K27me3
GSM706071H9 cell lineH3K4me1
GSM878612H9 cell lineDNase hypersensitivity
GSM878613H9 cell lineDNase hypersensitivity
GSM772738H9 derived neuron cultured cellsH3K9me3
GSM772776H9 derived neuron cultured cellsH3K4me3
GSM772785H9 derived neuron cultured cellsH3K4me1
GSM772787H9 derived neuron cultured cellsH3K27me3
GSM772736H9 derived neuronal progenitor cultured cellsH3K4me3
GSM772801H9 derived neuronal progenitor cultured cellsH3K27me3
GSM772808H9 derived neuronal progenitor cultured cellsH3K4me1
GSM772810H9 derived neuronal progenitor cultured cellsH3K9me3
GSM669936HUES48 cell lineH3K4me3
GSM669942HUES48 cell lineH3K27me3
GSM669954HUES48 cell lineH3K4me1
GSM772766HUES48 cell lineH3K27me3
GSM772780HUES48 cell lineH3K9me3
GSM772793HUES48 cell lineH3K4me1
GSM772797HUES48 cell lineH3K4me3
GSM772799HUES48 cell lineH3K9me3
GSM997250HUES48 cell lineH3K27ac
GSM669885HUES6 cell lineH3K4me1
GSM669886HUES6 cell lineH3K9me3
GSM669887HUES6 cell lineH3K27me3
GSM669889HUES6 cell lineH3K4me3
GSM669891HUES6 cell lineH3K4me1
GSM669893HUES6 cell lineH3K4me3
GSM669894HUES6 cell lineH3K9me3
GSM669897HUES6 cell lineH3K27me3
GSM1112774HUES6 cell lineH3K27ac
GSM1112776HUES6 cell lineH3K27ac
GSM669928HUES64 cell lineH3K9me3
GSM669966HUES64 cell lineH3K4me1
GSM669967HUES64 cell lineH3K4me3
GSM669974HUES64 cell lineH3K27me3
GSM772750HUES64 cell lineH3K27me3
GSM772752HUES64 cell lineH3K4me3
GSM772756HUES64 cell lineH3K9me3
GSM772800HUES64 cell lineH3K4me1
GSM772856HUES64 cell lineH3K9me3
GSM772971HUES64 cell lineH3K4me1
GSM772977HUES64 cell lineH3K27me3
GSM772978HUES64 cell lineH3K4me3
GSM773002HUES64 cell lineH3K27me3
GSM997249HUES64 cell lineH3K27ac
GSM1112775HUES64 cell lineH3K27ac
GSM468792IMR90 cell lineDNase hypersensitivity
GSM468801IMR90 cell lineDNase hypersensitivity
GSM469966IMR90 cell lineH3K27ac
GSM469967IMR90 cell lineH3K27ac
GSM469968IMR90 cell lineH3K27me3
GSM469970IMR90 cell lineH3K4me3
GSM469974IMR90 cell lineH3K9me3
GSM521887IMR90 cell lineH3K27ac
GSM521889IMR90 cell lineH3K27me3
GSM521895IMR90 cell lineH3K4me1
GSM521897IMR90 cell lineH3K4me1
GSM521898IMR90 cell lineH3K4me1
GSM521901IMR90 cell lineH3K4me3
GSM521913IMR90 cell lineH3K9me3
GSM521914IMR90 cell lineH3K9me3
GSM530665IMR90 cell lineDNase hypersensitivity
GSM530666IMR90 cell lineDNase hypersensitivity
GSM665801iPS DF 19.11 cell lineDNase hypersensitivity
GSM706065iPS DF 19.11 cell lineH3K27ac
GSM706067iPS DF 19.11 cell lineH3K27me3
GSM706072iPS DF 19.11 cell lineH3K4me1
GSM706074iPS DF 19.11 cell lineH3K4me3
GSM706079iPS DF 19.11 cell lineH3K9me3
GSM752965iPS DF 19.11 cell lineH3K27ac
GSM752966iPS DF 19.11 cell lineH3K27ac
GSM752970iPS DF 19.11 cell lineH3K27me3
GSM752979iPS DF 19.11 cell lineH3K4me1
GSM752984iPS DF 19.11 cell lineH3K4me3
GSM752988iPS DF 19.11 cell lineH3K9me3
GSM665800iPS DF 19.7 cell lineDNase hypersensitivity
GSM665803iPS DF 4.7 cell lineDNase hypersensitivity
GSM665802iPS DF 6.9 cell lineDNase hypersensitivity
GSM706068iPS DF 6.9 cell lineH3K27me3
GSM706073iPS DF 6.9 cell lineH3K4me1
GSM706075iPS DF 6.9 cell lineH3K4me3
GSM706080iPS DF 6.9 cell lineH3K9me3
GSM752967iPS DF 6.9 cell lineH3K27ac
GSM752971iPS DF 6.9 cell lineH3K27me3
GSM752980iPS DF 6.9 cell lineH3K4me1
GSM752985iPS DF 6.9 cell lineH3K4me3
GSM752989iPS DF 6.9 cell lineH3K9me3
GSM537694iPS-11a cell lineH3K4me3
GSM537687iPS-15b cell lineH3K4me3
GSM537691iPS-15b cell lineH3K9me3
GSM621433iPS-15b cell lineH3K27me3
GSM772767iPS-15b cell lineH3K4me1
GSM772935iPS-18a cell lineH3K27me3
GSM773023iPS-18a cell lineH3K9me3
GSM773028iPS-18a cell lineH3K4me1
GSM773029iPS-18a cell lineH3K4me3
GSM773033iPS-18a cell lineH3K27ac
GSM537671iPS-18c cell lineH3K4me3
GSM537674iPS-18c cell lineH3K27me3
GSM537676iPS-18c cell lineH3K4me3
GSM537678iPS-18c cell lineH3K9me3
GSM537688iPS-20b cell lineH3K9me3
GSM537700iPS-20b cell lineH3K27me3
GSM621416iPS-20b cell lineH3K27me3
GSM621423iPS-20b cell lineH3K4me3
GSM772804iPS-20b cell lineH3K4me1
GSM772842iPS-20b cell lineH3K9me3
GSM772844iPS-20b cell lineH3K4me3
GSM772845iPS-20b cell lineH3K4me1
GSM772847iPS-20b cell lineH3K27me3
GSM772848iPS-20b cell lineH3K27ac
GSM707003neurosphere cultured cells, cortex derivedH3K4me1
GSM707004neurosphere cultured cells, cortex derivedH3K4me3
GSM707005neurosphere cultured cells, cortex derivedH3K9me3
GSM707006neurosphere cultured cells, cortex derivedH3K27me3
GSM817230neurosphere cultured cells, cortex derivedH3K4me1
GSM817231neurosphere cultured cells, cortex derivedH3K9me3
GSM941713neurosphere cultured cells, cortex derivedH3K27me3
GSM707008neurosphere cultured cells, ganglionic eminence derivedH3K4me1
GSM707009neurosphere cultured cells, ganglionic eminence derivedH3K4me3
GSM707010neurosphere cultured cells, ganglionic eminence derivedH3K9me3
GSM707011neurosphere cultured cells, ganglionic eminence derivedH3K27me3
GSM817232neurosphere cultured cells, ganglionic eminence derivedH3K4me1
GSM817233neurosphere cultured cells, ganglionic eminence derivedH3K9me3
GSM941715neurosphere cultured cells, ganglionic eminence derivedH3K27me3
GSM1127062neurosphere cultured cells, ganglionic eminence derivedH3K4me3
GSM1127066neurosphere cultured cells, ganglionic eminence derivedH3K4me1
GSM1127078neurosphere cultured cells, ganglionic eminence derivedH3K27me3
GSM1127079neurosphere cultured cells, ganglionic eminence derivedH3K9me3
GSM1127083neurosphere cultured cells, ganglionic eminence derivedH3K27ac
GSM941748UCSF-4 cell lineH3K4me1
GSM941749UCSF-4 cell lineH3K4me3
GSM941750UCSF-4 cell lineH3K9me3
GSM941751UCSF-4 cell lineH3K27me3
GSM1127063UCSF-4 cell lineH3K4me3
GSM1127080UCSF-4 cell lineH3K4me1
GSM1127081UCSF-4 cell lineH3K9me3
GSM1127084UCSF-4 cell lineH3K27me3
Table 2

Data from ENCODE project in GEO database (or DCC Accession #).

GEO Accession #Sample Cell LineChIP AntibodyDCC Accession
GSM749677BJCTCFwgEncodeEH000403
BJH3K27me3wgEncodeEH000424
GSM945207BJH3K36me3wgEncodeEH000443
GSM945178BJH3K4me3wgEncodeEH000416
GSM822281FibroblCTCFwgEncodeEH001127
GSM822303GlioblaCTCFwgEncodeEH001135
GSM822302GlioblaPol2wgEncodeEH001136
H1-hESCATF2wgEncodeEH002316
GSM803512H1-hESCATF3wgEncodeEH001566
H1-hESCBach1wgEncodeEH002842
GSM803396H1-hESCBCL11AwgEncodeEH001527
GSM803476H1-hESCBCL11AwgEncodeEH001625
GSM935517H1-hESCBRCA1wgEncodeEH002801
H1-hESCCEBPBwgEncodeEH002825
GSM1003444H1-hESCCHD1wgEncodeEH002095
GSM935296H1-hESCCHD1wgEncodeEH002826
GSM935297H1-hESCCHD2wgEncodeEH002827
GSM1003473H1-hESCCHD7wgEncodeEH003136
GSM935614H1-hESCc-JunwgEncodeEH001854
GSM822274H1-hESCc-MycwgEncodeEH000596
H1-hESCc-MycwgEncodeEH002795
H1-hESCCREB1wgEncodeEH003229
H1-hESCCtBP2wgEncodeEH001767
GSM733672H1-hESCCTCFwgEncodeEH000085
GSM822297H1-hESCCTCFwgEncodeEH000560
GSM803419H1-hESCCTCFwgEncodeEH001649
GSM1010899H1-hESCE2F6wgEncodeEH003224
GSM803430H1-hESCEgr-1wgEncodeEH001538
GSM1003524H1-hESCEZH2wgEncodeEH003082
GSM803382H1-hESCFOSL1wgEncodeEH001660
GSM803424H1-hESCGABPwgEncodeEH001534
GSM935581H1-hESCGTF2F1wgEncodeEH002843
GSM1003579H1-hESCH2A.ZwgEncodeEH002082
GSM733718H1-hESCH3K27acwgEncodeEH000997
GSM733748H1-hESCH3K27me3wgEncodeEH000074
GSM733725H1-hESCH3K36me3wgEncodeEH000107
GSM733782H1-hESCH3K4me1wgEncodeEH000106
GSM733670H1-hESCH3K4me2wgEncodeEH000108
GSM733657H1-hESCH3K4me3wgEncodeEH000086
H1-hESCH3K79me2wgEncodeEH002083
GSM733773H1-hESCH3K9acwgEncodeEH000109
GSM1003585H1-hESCH3K9me3wgEncodeEH002084
GSM733687H1-hESCH4K20me1wgEncodeEH000087
GSM803345H1-hESCHDAC2wgEncodeEH001659
GSM1003472H1-hESCHDAC2wgEncodeEH003137
GSM1003571H1-hESCHDAC6wgEncodeEH003100
H1-hESCJARID1AwgEncodeEH002096
GSM1003479H1-hESCJMJD2AwgEncodeEH003138
GSM803529H1-hESCJunDwgEncodeEH001579
GSM935434H1-hESCJunDwgEncodeEH002023
H1-hESCMafKwgEncodeEH002828
GSM935348H1-hESCMaxwgEncodeEH001757
H1-hESCMaxwgEncodeEH003225
H1-hESCMaxwgEncodeEH003359
H1-hESCMxi1wgEncodeEH002829
GSM803437H1-hESCNANOGwgEncodeEH001635
GSM935308H1-hESCNrf1wgEncodeEH001847
GSM803365H1-hESCNRSFwgEncodeEH001498
GSM803542H1-hESCp300wgEncodeEH001574
GSM1003513H1-hESCP300wgEncodeEH003126
GSM1003509H1-hESCPHF8wgEncodeEH003094
GSM1003457H1-hESCPLU1wgEncodeEH003127
GSM822300H1-hESCPol2wgEncodeEH000563
GSM803366H1-hESCPol2wgEncodeEH001499
GSM803484H1-hESCPol2-4H8wgEncodeEH001514
GSM803438H1-hESCPOU5F1wgEncodeEH001636
GSM803466H1-hESCRad21wgEncodeEH001593
H1-hESCRad21wgEncodeEH001836
H1-hESCRBBP5wgEncodeEH002087
GSM935382H1-hESCRFX5wgEncodeEH001835
GSM803506H1-hESCRXRAwgEncodeEH001560
GSM1003572H1-hESCSAP30wgEncodeEH003101
GSM935289H1-hESCSIN3AwgEncodeEH002854
GSM803428H1-hESCSin3Ak-20wgEncodeEH001530
GSM1003451H1-hESCSIRT6wgEncodeEH003128
GSM803405H1-hESCSIX5wgEncodeEH001528
GSM803377H1-hESCSP1wgEncodeEH001529
H1-hESCSP2wgEncodeEH002302
GSM1010743H1-hESCSP4wgEncodeEH002317
GSM803425H1-hESCSRFwgEncodeEH001533
H1-hESCSUZ12wgEncodeEH001752
GSM1003573H1-hESCSUZ12wgEncodeEH003102
GSM803450H1-hESCTAF1wgEncodeEH001500
GSM803501H1-hESCTAF7wgEncodeEH001610
GSM935303H1-hESCTBPwgEncodeEH001848
GSM803427H1-hESCTCF12wgEncodeEH001531
GSM1010845H1-hESCTEAD4wgEncodeEH003214
GSM803426H1-hESCUSF-1wgEncodeEH001532
GSM935380H1-hESCUSF2wgEncodeEH001837
GSM803513H1-hESCYY1wgEncodeEH001567
H1-hESCZnf143wgEncodeEH002802
GSM1003619H1-hESCZNF274wgEncodeEH003357
GSM1010804H1-neuronsNRSFwgEncodeEH003264
H1-neuronsPol2-4H8wgEncodeEH003265
H1-neuronsTAF1wgEncodeEH003266
GSM749668HEK293CTCFwgEncodeEH000396
GSM935590HEK293ELK4wgEncodeEH001773
GSM945288HEK293H3K4me3wgEncodeEH000953
GSM935592HEK293KAP1wgEncodeEH001779
GSM935534HEK293Pol2wgEncodeEH000632
GSM782124HEK293TCF7L2wgEncodeEH002022
GSM935336K562ARID3AwgEncodeEH002861
GSM935340K562ATF1wgEncodeEH002865
GSM935391K562ATF3wgEncodeEH000700
GSM803380K562ATF3wgEncodeEH001662
K562Bach1wgEncodeEH002846
GSM803518K562BCL3wgEncodeEH001570
GSM803515K562BCLAF1wgEncodeEH001571
K562BDP1wgEncodeEH000678
K562BHLHE40wgEncodeEH001857
GSM935595K562BRF1wgEncodeEH000679
GSM935490K562BRF2wgEncodeEH000767
GSM935633K562Brg1wgEncodeEH000724
GSM1003574K562CBPwgEncodeEH003103
GSM1003567K562CBX2wgEncodeEH003104
GSM1010732K562CBX3wgEncodeEH002383
K562CBX3wgEncodeEH003105
K562CBX8wgEncodeEH003106
GSM935547K562CCNT2wgEncodeEH001864
GSM1003622K562CDPwgEncodeEH003391
GSM935499K562CEBPBwgEncodeEH001821
K562CEBPBwgEncodeEH002346
GSM1010906K562CEBPDwgEncodeEH003432
K562c-FoswgEncodeEH000619
K562CHD1wgEncodeEH002088
K562CHD2wgEncodeEH001822
GSM1003510K562CHD4wgEncodeEH003095
GSM1003478K562CHD7wgEncodeEH003139
GSM935411K562c-JunwgEncodeEH000620
GSM1003609K562c-JunwgEncodeEH003369
GSM822310K562c-MycwgEncodeEH000536
GSM935410K562c-MycwgEncodeEH000621
GSM935516K562c-MycwgEncodeEH002800
K562CORESTwgEncodeEH002814
K562CORESTwgEncodeEH002847
K562CREB1wgEncodeEH003230
GSM733719K562CTCFwgEncodeEH000042
GSM749690K562CTCFwgEncodeEH000399
GSM822311K562CTCFwgEncodeEH000535
GSM1010820K562CTCFwgEncodeEH002279
K562CTCFwgEncodeEH002279
GSM935407K562CTCFwgEncodeEH002797
GSM803401K562CTCFLwgEncodeEH001652
GSM935600K562E2F4wgEncodeEH000671
GSM935597K562E2F6wgEncodeEH000676
GSM803469K562E2F6wgEncodeEH001598
K562eGFP-BACH1wgEncodeEH002986
K562eGFP-CCNE1wgEncodeEH002996
K562eGFP-CDKN1BwgEncodeEH002997
K562eGFP-ELF1wgEncodeEH002998
K562eGFP-ESRwgEncodeEH002999
GSM777644K562eGFP-FOSwgEncodeEH001207
GSM777641K562eGFP-GATA2wgEncodeEH001208
GSM777640K562eGFP-HDAC8wgEncodeEH001209
K562eGFP-ILF2wgEncodeEH003000
GSM777638K562eGFP-JunBwgEncodeEH001210
GSM777639K562eGFP-JunDwgEncodeEH001211
K562eGFP-MLL5wgEncodeEH003001
K562eGFP-NCOR1wgEncodeEH003002
K562eGFP-NF90wgEncodeEH003003
GSM777637K562eGFP-NR4A1wgEncodeEH001212
K562eGFP-STAT1wgEncodeEH003004
GSM803414K562Egr-1wgEncodeEH001646
GSM803494K562ELF1wgEncodeEH001619
K562ELK1wgEncodeEH003356
GSM803442K562ETS1wgEncodeEH001580
K562EZH2wgEncodeEH002089
GSM803439K562FOSL1wgEncodeEH001637
GSM803524K562GABPwgEncodeEH001604
GSM1003608K562GATA1wgEncodeEH003368
GSM935540K562GATA-1wgEncodeEH000638
GSM803540K562GATA2wgEncodeEH001576
GSM935373K562GATA-2wgEncodeEH000683
GSM935394K562GTF2BwgEncodeEH000703
GSM935501K562GTF2F1wgEncodeEH001823
GSM733786K562H2A.ZwgEncodeEH001038
GSM733656K562H3K27acwgEncodeEH000043
GSM733658K562H3K27me3wgEncodeEH000044
GSM945228K562H3K27me3wgEncodeEH000434
GSM788088K562H3K27me3BwgEncodeEH000912
GSM733714K562H3K36me3wgEncodeEH000045
GSM945302K562H3K36me3wgEncodeEH000435
GSM733692K562H3K4me1wgEncodeEH000046
GSM788085K562H3K4me1wgEncodeEH000911
GSM733651K562H3K4me2wgEncodeEH000047
GSM733680K562H3K4me3wgEncodeEH000048
K562H3K4me3wgEncodeEH000400
GSM788087K562H3K4me3BwgEncodeEH000913
GSM733653K562H3K79me2wgEncodeEH001039
GSM733778K562H3K9acwgEncodeEH000049
GSM788082K562H3K9acBwgEncodeEH000914
GSM733777K562H3K9me1wgEncodeEH000050
GSM733776K562H3K9me3wgEncodeEH001040
GSM733675K562H4K20me1wgEncodeEH000051
K562HCFC1wgEncodeEH003392
GSM1003448K562HDAC1wgEncodeEH002090
GSM803471K562HDAC2wgEncodeEH001622
GSM1003447K562HDAC2wgEncodeEH002091
K562HDAC6wgEncodeEH003093
GSM803385K562HEY1wgEncodeEH001481
K562HMGN3wgEncodeEH001863
GSM935634K562Ini1wgEncodeEH000725
GSM935569K562JunDwgEncodeEH002164
GSM935464K562KAP1wgEncodeEH001764
GSM1003570K562LSD1wgEncodeEH003107
K562MafFwgEncodeEH002804
GSM935311K562MafKwgEncodeEH001844
GSM935539K562MaxwgEncodeEH000637
GSM803523K562MaxwgEncodeEH001605
GSM935344K562MaxwgEncodeEH002869
GSM935337K562MAZwgEncodeEH002862
GSM803379K562MEF2AwgEncodeEH001663
GSM935497K562Mxi1wgEncodeEH001827
K562NCoRwgEncodeEH003108
GSM935392K562NELFewgEncodeEH000701
K562NF-E2wgEncodeEH000624
K562NF-YAwgEncodeEH002021
GSM935429K562NF-YBwgEncodeEH002024
GSM1010782K562NR2F2wgEncodeEH002382
GSM935361K562Nrf1wgEncodeEH001796
GSM803440K562NRSFwgEncodeEH001638
GSM1003492K562NSD2wgEncodeEH003140
GSM935494K562p300wgEncodeEH001828
GSM1003583K562p300wgEncodeEH002086
GSM935401K562p300wgEncodeEH002834
GSM1003566K562PCAFwgEncodeEH003109
GSM1003450K562PHF8wgEncodeEH002092
GSM1003586K562PLU1wgEncodeEH002085
GSM1010722K562PMLwgEncodeEH002320
GSM822275K562Pol2wgEncodeEH000555
K562Pol2wgEncodeEH000616
GSM935632K562Pol2wgEncodeEH000727
GSM803410K562Pol2wgEncodeEH001633
GSM733643K562Pol2(b)wgEncodeEH000053
GSM935645K562Pol2(phosphoS2)wgEncodeEH001805
K562Pol2(phosphoS2)wgEncodeEH002833
GSM803443K562Pol2-4H8wgEncodeEH001581
GSM935481K562Pol3wgEncodeEH000694
GSM803384K562PU.1wgEncodeEH001482
GSM935319K562Rad21wgEncodeEH000649
GSM803447K562Rad21wgEncodeEH001585
K562RBBP5wgEncodeEH002093
GSM1003507K562RESTwgEncodeEH003096
GSM935565K562RFX5wgEncodeEH002033
GSM1003563K562RNF2wgEncodeEH003110
GSM935372K562RPC155wgEncodeEH000680
GSM1003445K562SAP30wgEncodeEH002094
GSM935598K562SETDB1wgEncodeEH000677
GSM1003452K562SETDB1wgEncodeEH003129
GSM803525K562Sin3Ak-20wgEncodeEH001607
K562SIRT6wgEncodeEH000681
GSM1003560K562SIRT6wgEncodeEH003111
GSM803383K562SIX5wgEncodeEH001483
GSM803378K562SIX5wgEncodeEH001664
K562SMC3wgEncodeEH001845
GSM803505K562SP1wgEncodeEH001578
GSM803402K562SP2wgEncodeEH001653
GSM803520K562SRFwgEncodeEH001600
GSM1010877K562STAT5AwgEncodeEH002347
GSM1003545K562SUZ12wgEncodeEH003112
GSM803431K562TAF1wgEncodeEH001582
GSM803407K562TAF7wgEncodeEH001654
K562TAL1wgEncodeEH001824
GSM935574K562TBLR1wgEncodeEH002848
K562TBLR1wgEncodeEH002849
GSM935495K562TBPwgEncodeEH001825
K562TEAD4wgEncodeEH002333
GSM935343K562TFIIIC-110wgEncodeEH000748
GSM803408K562THAP1wgEncodeEH001655
GSM935374K562TR4wgEncodeEH000682
GSM1010849K562TRIM28wgEncodeEH003210
GSM935338K562UBFwgEncodeEH002863
K562UBTFwgEncodeEH002850
GSM803441K562USF-1wgEncodeEH001583
K562USF2wgEncodeEH001797
GSM935425K562XRCC4wgEncodeEH000650
K562YY1wgEncodeEH000684
GSM803446K562YY1wgEncodeEH001584
GSM803470K562YY1wgEncodeEH001623
GSM803504K562ZBTB33wgEncodeEH001569
GSM803473K562ZBTB7AwgEncodeEH001620
K562ZC3H11AwgEncodeEH003380
GSM935568K562Znf143wgEncodeEH002030
K562ZNF263wgEncodeEH000630
GSM935479K562ZNF274wgEncodeEH000696
GSM935503K562ZNF274wgEncodeEH002068
GSM1003621K562ZNF384wgEncodeEH003382
GSM1003611K562ZNF-MIZD-CP1wgEncodeEH003381
GSM733744NHDF-AdCTCFwgEncodeEH001048
NHDF-AdEZH2wgEncodeEH002438
GSM1003505NHDF-AdH2A.ZwgEncodeEH003090
GSM733662NHDF-AdH3K27acwgEncodeEH001049
GSM733745NHDF-AdH3K27me3wgEncodeEH001050
GSM733733NHDF-AdH3K36me3wgEncodeEH001051
GSM1003526NHDF-AdH3K4me1wgEncodeEH002429
GSM733753NHDF-AdH3K4me2wgEncodeEH001052
GSM733650NHDF-AdH3K4me3wgEncodeEH001053
GSM1003554NHDF-AdH3K79me2wgEncodeEH002430
GSM733709NHDF-AdH3K9acwgEncodeEH001054
GSM1003553NHDF-AdH3K9me3wgEncodeEH002431
GSM1003486NHDF-AdH4K20me1wgEncodeEH002417
WI-38CTCFwgEncodeEH001902
GSM945265WI-38H3K4me3wgEncodeEH001914
The genome regions surrounding known let-7 gene locations were surveyed for the presence of histone modifications and open chromatin in cell types representative of the stages of differentiation from PSCs to NPCs and neurons. We also imported miRNA gene transcripts in cells lacking DGCR8 from Chang et al, which are accessible using the NIH SRA database, accession SRP057660. Together, these data allowed us to identify primary let-7 transcripts, based on their expression in our Chromatin-associated RNA-seq samples and in DGCR8-/- RNA-seq samples, even when they disagreed with RefSeq-annotated MIRLET7 genes. Hypothesized regulatory regions were assembled by searching 20 kilobases upstream and downstream of each transcript for colocalization of H3K27Ac, H3K4me3, and DNAse sensitivity in samples known to express let-7 primary transcripts, and H3K27me3 or H3K9me3 in samples without appreciable primary let-7 transcripts. These regions were frequently annotated as Active TSS, Flanking active TSS, Bivalent/Poised TSS, Enhancer, Genic Enhancer, and Bivalent Enhancer in the ChromHMM chromatin state prediction algorithm performed on Roadmap datasets. These hypothesized regulatory regions were then queried for transcription factor binding sites, based on known and predicted TF binding sites and motifs. We used both the ORCA Toolkit web server and the MEME suite of motif analysis applications to isolate highly conserved (>80% phastCons score) sub-regions within these hypothesized regulatory regions, and then queried those conserved sub-regions for TF motifs. These motifs were assembled from the JASPAR motif database as well as a small list of manually curated motif sequences. Where possible, experimental ChIP-Seq validated TF binding sites from ENCODE and ROADMAP dataset were used as secondary validation of predicted TF binding sites. Accession numbers for these datasets are also found in Tables 1 and 2.

Complete annotation of let-7 miRNA transcripts and regulation in human PSCs and NPCs by Chromatin RNA-seq.

Shown are each of the let-7 family member transcripts, including polycistrons. The top of the graphic shows the genomic locus. The middle section are data from the Chromatin RNA-seq described in Fig 1. Below in green are the annotations for let-7 miRNAs described in Cheng et al in the indicated cell types. Below in blue are the annotations according to public genome browsers. (PDF) Click here for additional data file.

Annotation of epigenetic marks at two let-7 polycistronic loci.

Epigenetic marks from the Roadmap Epigenomics project at the dynamic (let-7a3/b) and constitutive (let-7a1/d1/f1) polycistronic loci. At top are the Chromatin-associated RNA-Seq peaks and RefSeq annotations of the primary let-7 transcripts, and below are the relative intensities of DNAse sensitivity or histone modification ChIP-Seq peaks at those loci. (PDF) Click here for additional data file.

Complete annotation of let-7 miRNA transcripts and summary of available data on epigenetic marks across various cell types.

Shown are the let-7 genomic loci with accompanying epigenetic marks as identified by ChIP-seq data available from the epigenetic roadmap across the indicated cell types. The bottom portion also includes available ChIP-seq data on the indicated transcription factor binding patterns at these same loci. (PDF) Click here for additional data file.
  41 in total

1.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.

Authors:  B J Reinhart; F J Slack; M Basson; A E Pasquinelli; J C Bettinger; A E Rougvie; H R Horvitz; G Ruvkun
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  The temporal patterning microRNA let-7 regulates several transcription factors at the larval to adult transition in C. elegans.

Authors:  Helge Grosshans; Ted Johnson; Kristy L Reinert; Mark Gerstein; Frank J Slack
Journal:  Dev Cell       Date:  2005-03       Impact factor: 12.270

Review 3.  The microRNA-argonaute complex: a platform for mRNA modulation.

Authors:  Christopher M Hammell
Journal:  RNA Biol       Date:  2008-07-08       Impact factor: 4.652

4.  Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA.

Authors:  Takashi Sekiya; Uma M Muthurajan; Karolin Luger; Alexei V Tulin; Kenneth S Zaret
Journal:  Genes Dev       Date:  2009-04-01       Impact factor: 11.361

5.  Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing.

Authors:  A Grishok; A E Pasquinelli; D Conte; N Li; S Parrish; I Ha; D L Baillie; A Fire; G Ruvkun; C C Mello
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

6.  MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.

Authors:  Nagalakshmi Nadiminty; Ramakumar Tummala; Wei Lou; Yezi Zhu; Jin Zhang; Xinbin Chen; Ralph W eVere White; Hsing-Jien Kung; Christopher P Evans; Allen C Gao
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

7.  Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.

Authors:  Abdenour Soufi; Greg Donahue; Kenneth S Zaret
Journal:  Cell       Date:  2012-11-15       Impact factor: 41.582

8.  Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.

Authors:  Åslaug Helland; Michael S Anglesio; Joshy George; Prue A Cowin; Cameron N Johnstone; Colin M House; Karen E Sheppard; Dariush Etemadmoghadam; Nataliya Melnyk; Anil K Rustgi; Wayne A Phillips; Hilde Johnsen; Ruth Holm; Gunnar B Kristensen; Michael J Birrer; Richard B Pearson; Anne-Lise Børresen-Dale; David G Huntsman; Anna deFazio; Chad J Creighton; Gordon K Smyth; David D L Bowtell
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

9.  Defining the role of oxygen tension in human neural progenitor fate.

Authors:  Yuan Xie; Jin Zhang; Ying Lin; Xavier Gaeta; Xiangzhi Meng; Dona R R Wisidagama; Jessica Cinkornpumin; Carla M Koehler; Cindy S Malone; Michael A Teitell; William E Lowry
Journal:  Stem Cell Reports       Date:  2014-10-30       Impact factor: 7.765

10.  Selective blockade of microRNA processing by Lin28.

Authors:  Srinivas R Viswanathan; George Q Daley; Richard I Gregory
Journal:  Science       Date:  2008-02-21       Impact factor: 47.728

View more
  3 in total

1.  A high-resolution mRNA expression time course of embryonic development in zebrafish.

Authors:  Richard J White; John E Collins; Ian M Sealy; Neha Wali; Christopher M Dooley; Zsofia Digby; Derek L Stemple; Daniel N Murphy; Konstantinos Billis; Thibaut Hourlier; Anja Füllgrabe; Matthew P Davis; Anton J Enright; Elisabeth M Busch-Nentwich
Journal:  Elife       Date:  2017-11-16       Impact factor: 8.140

Review 2.  Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer.

Authors:  Evgeny Chirshev; Kerby C Oberg; Yevgeniya J Ioffe; Juli J Unternaehrer
Journal:  Clin Transl Med       Date:  2019-08-28

3.  EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis.

Authors:  Chenying Fu; Qing Zhang; Ani Wang; Songpeng Yang; Yangfu Jiang; Lin Bai; Quan Wei
Journal:  Mol Oncol       Date:  2021-03-27       Impact factor: 6.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.